Status:
COMPLETED
Gelsemium Sempervirens in Anticipatory Anxiety
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
BOIRON
Conditions:
Anxiety
Eligibility:
All Genders
18-40 years
Phase:
PHASE3
Brief Summary
To evaluate the effectiveness of Gelsemium sempervirens 5CH et 15CH on anticipatory provoked anxiety, in healthy volunteers.
Detailed Description
State-anxiety can appear during banal events without objective harrowing factors. It is preponderant in particular situations as exams and competitive examination for example, and may be responsible o...
Eligibility Criteria
Inclusion
- Man or woman,
- age between 18 et 40 ans,
- affiliated to a regime of social security or equivalent
Exclusion
- Medical history of psychiatric disease relevant of psychoses,
- Medical history of hospitalisation in psychiatric environment,
- psychotropic substance of the class of antidepressants, antipsychotics and normothymics), in the year before inclusion,
- Taking, even punctual of psychotropics substances of the class of benzodiazepines and related, in the month before inclusion,
- Taking, even punctual of psychotropics substances of the class of anxiolytics non benzodiazepines, in the month before inclusion: meprobamate, hydroxyzine, buspirone, captodiamine, pregabalin, etifoxine,
- Taking, even punctual of substances of the class of the sedatives divers, in the month before inclusion: phytotherapy, homeopathy, sedatives with brome, mineral elements,
- Taking, even punctual of substances of the class of antihistamine with hypnotic aim, in the month before inclusion,
- Taking, even punctual of propanolol in the month before inclusion
- Known Addiction,
- Handicap incompatible with the Stress Test : blindness, partially sighted, daltonism, dementia, language troubles,
- Pregnancy, parturient and nursing woman,
- Person private of freedom by judicial or administrative decision, person under measure of legal protection,
- allergy to one of the constituents
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT00914329
Start Date
June 1 2009
End Date
May 1 2010
Last Update
June 3 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Center
Grenoble, France, 38043